Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
eltanexor (KPT-8602)
i
Other names:
ATG 016, KPT8602, ONO7706, ONO 7706, KPT-8602, KPT 8602, ATG-016, ONO-7706, ATG016
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(5)
News
Trials
Company:
Antengene, Karyopharm, Ono Pharma
Drug class:
XPO1 inhibitor, Nuclear export inhibitor
Related drugs:
‹
selinexor (47)
CBS9106 (1)
selinexor (47)
CBS9106 (1)
›
Associations
(5)
News
Trials
VERI cancer hierarchy
Reset Filters
No biomarker
Myelodysplastic Syndrome
No biomarker
Myelodysplastic Syndrome
KPT-8602
Sensitive: B - Late Trials
KPT-8602
Sensitive
:
B
KPT-8602
Sensitive: B - Late Trials
KPT-8602
Sensitive
:
B
KRAS mutation
Colorectal Cancer
KRAS mutation
Colorectal Cancer
KPT-8602
Sensitive: C3 – Early Trials
KPT-8602
Sensitive
:
C3
KPT-8602
Sensitive: C3 – Early Trials
KPT-8602
Sensitive
:
C3
BCR-ABL1 fusion
Acute Lymphocytic Leukemia
BCR-ABL1 fusion
Acute Lymphocytic Leukemia
KPT-8602
Sensitive: D – Preclinical
KPT-8602
Sensitive
:
D
KPT-8602
Sensitive: D – Preclinical
KPT-8602
Sensitive
:
D
ER Y537S
Estrogen Receptor Positive Breast Cancer
ER Y537S
Estrogen Receptor Positive Breast Cancer
KPT-8602
Sensitive: D – Preclinical
KPT-8602
Sensitive
:
D
KPT-8602
Sensitive: D – Preclinical
KPT-8602
Sensitive
:
D
ER D538G
Estrogen Receptor Positive Breast Cancer
ER D538G
Estrogen Receptor Positive Breast Cancer
KPT-8602
Sensitive: D – Preclinical
KPT-8602
Sensitive
:
D
KPT-8602
Sensitive: D – Preclinical
KPT-8602
Sensitive
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.